StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma cash

Cash and short-term investments held at the end of each period.

Integrated BioPharma's cash was $4.47M at Jun 30, 2026. For fiscal 2026 it was $4.47M, up 23.7% from the year before. Over ten years it grew 27.5% a year on average. The highest annual figure on record is $4.47M in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$4.47M+23.7%
FY2025Jun 30, 2025$3.62M+115.6%
FY2024Jun 30, 2024$1.68M+27.4%
FY2023Jun 30, 2023$1.32M+297.6%
FY2022Jun 30, 2022$331.00K+57.6%
FY2021Jun 30, 2021$210.00K-47.8%
FY2020Jun 30, 2020$402.00K-15.4%
FY2019Jun 30, 2019$475.00K+108.3%
FY2018Jun 30, 2018$228.00K+72.7%
FY2017Jun 30, 2017$132.00K-66.6%
FY2016Jun 30, 2016$395.00K+456.3%
FY2015Jun 30, 2015$71.00K-84.3%
FY2014Jun 30, 2014$451.00K+720.0%
FY2013Jun 30, 2013$55.00K-62.1%
FY2012Jun 30, 2012$145.00K-80.0%
FY2011Jun 30, 2011$725.00K+12.1%
FY2010Jun 30, 2010$647.00K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$4.47M+23.7%
Q3 FY2026CQ1 2026Mar 31, 2026$5.83M+96.8%
Q2 FY2026CQ4 2025Dec 31, 2025$5.31M+115.9%
Q1 FY2026CQ3 2025Sep 30, 2025$4.73M+108.4%
Q4 FY2025CQ2 2025Jun 30, 2025$3.62M+115.6%
Q3 FY2025CQ1 2025Mar 31, 2025$2.96M+46.6%
Q2 FY2025CQ4 2024Dec 31, 2024$2.46M+236.2%
Q1 FY2025CQ3 2024Sep 30, 2024$2.27M-12.5%
Q4 FY2024CQ2 2024Jun 30, 2024$1.68M+27.4%
Q3 FY2024CQ1 2024Mar 31, 2024$2.02M-20.1%
Q2 FY2024CQ4 2023Dec 31, 2023$732.00K-32.5%
Q1 FY2024CQ3 2023Sep 30, 2023$2.59M+122.1%
Q4 FY2023CQ2 2023Jun 30, 2023$1.32M+297.6%
Q3 FY2023CQ1 2023Mar 31, 2023$2.53M+858.0%
Q2 FY2023CQ4 2022Dec 31, 2022$1.09M+569.8%
Q1 FY2023CQ3 2022Sep 30, 2022$1.17M+1949.1%
Q4 FY2022CQ2 2022Jun 30, 2022$331.00K+57.6%
Q3 FY2022CQ1 2022Mar 31, 2022$264.00K+151.4%
Q2 FY2022CQ4 2021Dec 31, 2021$162.00K+276.7%
Q1 FY2022CQ3 2021Sep 30, 2021$57.00K-84.6%
Q4 FY2021CQ2 2021Jun 30, 2021$210.00K-47.8%
Q3 FY2021CQ1 2021Mar 31, 2021$105.00K-81.4%
Q2 FY2021CQ4 2020Dec 31, 2020$43.00K-35.8%
Q1 FY2021CQ3 2020Sep 30, 2020$369.00K-29.7%
Q4 FY2020CQ2 2020Jun 30, 2020$402.00K-15.4%
Q3 FY2020CQ1 2020Mar 31, 2020$565.00K+31.1%
Q2 FY2020CQ4 2019Dec 31, 2019$67.00K+48.9%
Q1 FY2020CQ3 2019Sep 30, 2019$525.00K+43.8%
Q4 FY2019CQ2 2019Jun 30, 2019$475.00K+108.3%
Q3 FY2019CQ1 2019Mar 31, 2019$431.00K+595.2%
Q2 FY2019CQ4 2018Dec 31, 2018$45.00K-16.7%
Q1 FY2019CQ3 2018Sep 30, 2018$365.00K+28.5%
Q4 FY2018CQ2 2018Jun 30, 2018$228.00K+72.7%
Q3 FY2018CQ1 2018Mar 31, 2018$62.00K-68.4%
Q2 FY2018CQ4 2017Dec 31, 2017$54.00K-18.2%
Q1 FY2018CQ3 2017Sep 30, 2017$284.00K+208.7%
Q4 FY2017CQ2 2017Jun 30, 2017$132.00K–
Q3 FY2017CQ1 2017Mar 31, 2017$196.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$66.00K–
Q1 FY2017CQ3 2016Sep 30, 2016$92.00K–

More Integrated BioPharma figures

See a number that looks wrong?